Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Wed Apr 02 09:34:04 GMT 2025
by
admin
on
Wed Apr 02 09:34:04 GMT 2025
|
| Protein Sub Type | |
| Sequence Type | COMPLETE |
| Record UNII |
AWV6I5L6H2
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Related Record | Type |
|---|
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C263
Created by
admin on Wed Apr 02 09:34:04 GMT 2025 , Edited by admin on Wed Apr 02 09:34:04 GMT 2025
|
||
|
FDA ORPHAN DRUG |
246807
Created by
admin on Wed Apr 02 09:34:04 GMT 2025 , Edited by admin on Wed Apr 02 09:34:04 GMT 2025
|
||
|
EMA ASSESSMENT REPORTS |
ATRYN (AUTHORIZED: ANTITHROMBIN III DEFICIENCY)
Created by
admin on Wed Apr 02 09:34:04 GMT 2025 , Edited by admin on Wed Apr 02 09:34:04 GMT 2025
|
||
|
FDA ORPHAN DRUG |
118798
Created by
admin on Wed Apr 02 09:34:04 GMT 2025 , Edited by admin on Wed Apr 02 09:34:04 GMT 2025
|
||
|
NDF-RT |
N0000184170
Created by
admin on Wed Apr 02 09:34:04 GMT 2025 , Edited by admin on Wed Apr 02 09:34:04 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL1201554
Created by
admin on Wed Apr 02 09:34:04 GMT 2025 , Edited by admin on Wed Apr 02 09:34:04 GMT 2025
|
PRIMARY | |||
|
8429
Created by
admin on Wed Apr 02 09:34:04 GMT 2025 , Edited by admin on Wed Apr 02 09:34:04 GMT 2025
|
PRIMARY | |||
|
AWV6I5L6H2
Created by
admin on Wed Apr 02 09:34:04 GMT 2025 , Edited by admin on Wed Apr 02 09:34:04 GMT 2025
|
PRIMARY | |||
|
100000087989
Created by
admin on Wed Apr 02 09:34:04 GMT 2025 , Edited by admin on Wed Apr 02 09:34:04 GMT 2025
|
PRIMARY | |||
|
84720-88-7
Created by
admin on Wed Apr 02 09:34:04 GMT 2025 , Edited by admin on Wed Apr 02 09:34:04 GMT 2025
|
PRIMARY | |||
|
1427179
Created by
admin on Wed Apr 02 09:34:04 GMT 2025 , Edited by admin on Wed Apr 02 09:34:04 GMT 2025
|
PRIMARY | RxNorm | ||
|
SUB22365
Created by
admin on Wed Apr 02 09:34:04 GMT 2025 , Edited by admin on Wed Apr 02 09:34:04 GMT 2025
|
PRIMARY | |||
|
N0000008556
Created by
admin on Wed Apr 02 09:34:04 GMT 2025 , Edited by admin on Wed Apr 02 09:34:04 GMT 2025
|
PRIMARY | Decreased Coagulation Factor Activity [PE] | ||
|
C82234
Created by
admin on Wed Apr 02 09:34:04 GMT 2025 , Edited by admin on Wed Apr 02 09:34:04 GMT 2025
|
PRIMARY | |||
|
DB11166
Created by
admin on Wed Apr 02 09:34:04 GMT 2025 , Edited by admin on Wed Apr 02 09:34:04 GMT 2025
|
PRIMARY | |||
|
P01008
Created by
admin on Wed Apr 02 09:34:04 GMT 2025 , Edited by admin on Wed Apr 02 09:34:04 GMT 2025
|
PRIMARY | |||
|
TT-126
Created by
admin on Wed Apr 02 09:34:04 GMT 2025 , Edited by admin on Wed Apr 02 09:34:04 GMT 2025
|
PRIMARY |
| From | To |
|---|---|
| 1_8 | 1_128 |
| 1_21 | 1_95 |
| 1_247 | 1_430 |
| Glycosylation Type | MAMMALIAN |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_96 |
| N | 1_135 |
| N | 1_155 |
| N | 1_192 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SUB_CONCEPT->SUBSTANCE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
Structural Modifications
| Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
|---|---|---|---|---|---|---|
| AMINO ACID SUBSTITUTION | [1_36] | S | DEXFOSFOSERINE | VI4F0K069V |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Molecular Formula | CHEMICAL |
|
||||
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|